Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10708 |
CCR1 antagonist 6
|
CCR | Immunology/Inflammation; Microbiology/Virology |
CCR1 antagonist 6是一种 CCR1 拮抗剂(IC50 :3 nM)。 | |||
T15253 |
CCX354
CCR1 antagonist 1,CCX-354,CCX 354 |
CCR | Immunology/Inflammation; Microbiology/Virology |
CCX354 (CCR1 antagonist 1) 是一种有效的小分子 CCR1 拮抗剂,具有抗炎活性,可用于治疗类风湿关节炎。 | |||
T30258 |
AZD-4818
CCR1 antagonist |
CCR | Immunology/Inflammation; Microbiology/Virology |
AZD-4818 (CCR1 antagonist) 是趋化因子CCR1的一种拮抗剂,可用于研究慢性阻塞性肺病。 | |||
T77349 |
CCR1/5/8 activator 1
|
Phospholipase | Metabolism |
CCR1/5/8 activator 1 是胞质磷脂酶 A 抑制剂,具有抗真菌活性。 | |||
T10709 |
CCR1 antagonist 7
|
CCR | Immunology/Inflammation; Microbiology/Virology |
CCR1 antagonist 7 (compound 16r) 是CCR1的拮抗剂,IC50值为 4 nM。 | |||
T14899 |
CCR1 antagonist 8
|
CCR | Immunology/Inflammation; Microbiology/Virology |
CCR1 antagonist 8, a third azaindazole series compound, is a CCR1 antagonist (IC50: 1.8 nM in Ca2+ flux assay). | |||
T10710 |
CCR1 antagonist 9
|
CCR | Immunology/Inflammation; Microbiology/Virology |
CCR1 antagonist 9 is an effective and selective CCR1 antagonist (IC50: 6.8 nM in calcium flux assay). | |||
T28072 |
MLN-3897
AVE9897,AVE 9897,CCR1 antagonist 10,AVE-9897 |
CCR | Immunology/Inflammation; Microbiology/Virology |
MLN-3897 (CCR1 antagonist 10) 是一种具有口服活性的 CCR1 拮抗剂,对于 125I-MIP-1α 与 THP-1 细胞膜的结合,Ki 为 2.3 nM。 MLN-3897 抑制 Akt 信号转导和 MM 细胞存活和增殖。 | |||
T64242 | CCR1 antagonist 11 hydrochloride | ||
CCR1 antagonist 11 hydrochloride (A1B1) 是一种口服具有活力的 CCR1 拮抗剂,能够作用于 hCCR1 (IC50: 0/。03 μM)、mCCR1 (IC50: 0.58 μM)、rCCR1 (IC50: 0.32 μM)。CCR1 antagonist 11 hydrochloride 能够用于研究类风湿性关节炎等相关炎症性疾病。 | |||
T11699 |
J-113863
|
CCR | Immunology/Inflammation; Microbiology/Virology |
J-113863 是选择性的 CCR1 (CD18)拮抗剂,有抗炎作用,对人和小鼠 CCR1受体的 IC50值分别为 0.9 和 5.8 nM。它是人 CCR3的强效拮抗剂,还是小鼠 CCR3的弱效拮抗剂,IC50分别为 0.58 和 460 nM。 | |||
T2375 |
BX471
BX 471,BX-471,ZK-811752 |
CCR | Immunology/Inflammation; Microbiology/Virology |
BX471 (BX 471) 是可口服的非多肽 CCR1选择性拮抗剂,Ki 值为 1 nM,对其选择性是对 CCR2、CCR5 和 CXCR4 的 250 倍。 | |||
T26861 |
BMS-817399
BMS817399 |
CCR | Immunology/Inflammation; Microbiology/Virology |
BMS-817399 是一种具有口服活性的 CCR1 拮抗剂,具有结合亲和力和趋化性抑制效力的 IC50,可用于类风湿性关节炎的研究。 | |||
T28072L |
MLN-3897 TFA
MLN-3897 TFA(1010731-97-1 Free base) |
CCR | Immunology/Inflammation; Microbiology/Virology |
MLN-3897 TFA 是一种有效的CCR1 拮抗剂,对 125I-MIP-1α 与 THP-1 细胞膜的结合具有抑制作用。 | |||
TQ0283 |
RS102895
|
CCR | Immunology/Inflammation; Microbiology/Virology |
RS102895 是一种CCR2拮抗剂,IC50值为 360 nM。 | |||
T5384 |
RS 504393
|
CCR | Immunology/Inflammation; Microbiology/Virology |
RS 504393 是一种高度选择性的 CCR2 趋化因子受体拮抗剂,作用于人重组 CCR2 和 CCR1 受体,IC50值分别为 89 nM 和大于 100 μM。 | |||
T3188 |
RE-640
|
CCR; Parasite | Immunology/Inflammation; Microbiology/Virology |
NSC-5844 (RE-640) 是 4-氨基喹啉衍生物,起抗肿瘤和抗疟疾作用。 | |||
T14845 |
BX471 hydrochloride
ZK-811752 hydrochloride |
Others | Others |
BX471 hydrochloride (ZK-811752 hydrochloride) is a potent, selective non-peptide CCR1 antagonist (Ki: 1 nM for human CCR1). It shows 250-fold selectivity for CCR1 over CCR2, CCR5, and CXCR4. | |||
T23492 |
UCB 35625
|
Others | Others |
chemokine CCR1 and CCR3 receptor antagonist | |||
T26849 | BMS-457 | ||
BMS-457 is a potent, CCR1-selective antagonist. | |||
T68427 |
MLN-3897 citrate
|
||
MLN-3897 citrate is a C-C Motif Chemokine Receptor 1 (CCR1) antagonist potentially for the treatment of multiple sclerosis and rheumatoid arthritis. | |||
T31061 |
CP-481715
CP 481,715,CP-481,715,CP481715,CP481,715 |
||
CP 481715 is an effective selective CCR1 antagonist with potential therapeutic significance for inflammatory diseases. | |||
T73371 |
BAY-3153
|
||
BAY-3153 是一种选择性的 CCR1(C-C motifchemokine receptor1) 拮抗剂 (humanIC50=3 nM ; ratIC50=11 nM ; miceIC50=81 nM)。 | |||
T71905 |
BX-513 HCl
|
||
BX-513 HCl is a selective CCR1 receptor antagonist. | |||
T12773 |
RS102895 hydrochloride
RS102895盐酸盐 |
Others; 5-HT Receptor; CCR | GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Neuroscience; Others |
RS102895 hydrochloride 是一种CCR2拮抗剂,IC50值为 360 nM。 | |||
T41016 |
Vercirnon sodium
GSK-1605786 sodium,CCX282-Bsodium,维塞诺钠盐,Traficet-ENsodium |
||
Vercirnon (GSK1605786A) sodium is an orally bioavailable, selective, and potent antagonist of CCR9 . Vercirnon sodium inhibits CCR9-mediated Ca 2+ mobilization and chemotaxis on Molt-4 cells with IC 50 values of 5.4 and 3.4 nM, respectively. Vercirnon sodium is selective for CCR9 over CCR1-12 and CX3CR1-7 (IC 50 s>10 μM for all). Vercirnon sodium is an equipotent inhibitor of CCL25-directed chemotaxis of both splice forms of CCR9 (CCR9A and CCR9B) with IC 50 values of 2.8 and 2.6 nM, respectivel... | |||
T17274 |
YM022
|
CCR | Immunology/Inflammation; Microbiology/Virology |
YM022 is a highly effective and selective gastrin/cholecystokinin (CCK)-B receptor antagonist. YM022 can inhibit gastrin-induced gastric acid secretion and histidine decarboxylase activation in vivo. YM022 shows the Ki values of 68 pM and 63 nM for CCK-B and CCK-A receptor, respectively. |